Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005856 220011269 null null Palliative (P) 2015-02-25 2015-02-25 Nilotinib null Y 220029112 NILOTINIB
220005857 220002285 1.75 61.5 Curative (C) null 2017-06-27 FLAG + Idarubicin N N 220029118 FLAG + IDARUBICIN
220005858 220002285 1.73 75 null 2013-10-04 2013-10-04 FLAG + Idarubicin Y N 220029118 FLAG + IDARUBICIN
220005859 220002286 1.69 98.2 null 2014-03-09 2014-03-12 FLAG + Idarubicin 2 N 220029122 FLAG + IDARUBICIN
220005860 220002286 1.7 79.2 Curative (C) 2015-05-18 2015-05-21 AML 19 TRIAL N N 220029122 AML19 TRIAL
220005861 220002286 1.68 69.8 Curative (C) 2016-11-21 2016-11-22 AML 19 TRIAL null null 220029122 AML19 TRIAL
220005862 220002286 1.68 80.3 Curative (C) 2016-10-28 2016-10-28 AML 19 TRIAL Y null 220029122 AML19 TRIAL
220005863 220002287 1.75 null Curative (C) 2013-05-19 2013-05-19 FLAG + Idarubicin N N 220029130 FLAG + IDARUBICIN
220005864 220002287 1.74 null null null 2014-11-12 FLAG + Idarubicin 2 N 220029130 FLAG + IDARUBICIN
220005865 220002288 1.74 43.3 Curative (C) 2013-12-20 2013-12-27 FLAG + Idarubicin null N 220029133 FLAG + IDARUBICIN
220005866 220002288 0 0 Curative (C) 2015-08-22 2015-08-23 Nilotinib 02 Y 220029133 NILOTINIB
220005867 220002288 1.63 95.2 Curative (C) 2013-06-13 2013-06-13 FLAG + Idarubicin N N 220029133 FLAG + IDARUBICIN
220005868 220002289 null null Palliative (P) 2016-07-29 2016-07-29 CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + VINCRISTINE 1 N 220029142 NOT MATCHED
220005869 220002290 1.78 null Curative (C) 2017-11-26 2017-11-29 Nilotinib N N 220029144 NILOTINIB
220005870 220002290 1.65 81 Curative (C) 2013-03-15 2013-03-15 AML 19 TRIAL N N 220029144 AML19 TRIAL
220005871 220002290 1.57 56 Curative (C) 2013-09-15 2013-09-18 AML 19 TRIAL null N 220029144 AML19 TRIAL
220005872 220002290 1.77 72.1 Disease modification (D) null 2016-02-07 AML 19 TRIAL Y N 220029144 AML19 TRIAL
220005873 220002290 1.58 88 Curative (C) 2016-02-07 2016-02-07 AML 19 TRIAL 1 N 220029144 AML19 TRIAL
220005874 220002291 0 null null 2016-11-10 2016-11-11 Nilotinib N N 220029152 NILOTINIB
220005875 220011275 1.59 104.2 Curative (C) 2017-10-02 2017-10-02 AML 19 TRIAL 01 null 220029155 AML19 TRIAL
220005876 220002292 1.8 null Adjuvant (A) 2017-02-16 2017-02-18 AML Interim Guidelines FLA -Ida N N 220029162 NOT MATCHED
220005877 220011276 1.6 96.2 null 2016-11-12 2016-11-16 Nilotinib N N 220029163 NILOTINIB
220005878 220002293 1.75 77.8 Curative (C) 2013-07-10 2013-07-11 AML 19 TRIAL Y N 220029166 AML19 TRIAL
220005882 220002295 1.72 87.8 Curative (C) 2013-06-06 2013-06-06 FLAG + Idarubicin null N 220029174 FLAG + IDARUBICIN
220005883 220002295 0 null Disease modification (D) 2015-03-25 2015-03-25 Nilotinib N N 220029174 NILOTINIB
220005884 220002295 1.64 79.8 Curative (C) 2015-05-17 2015-05-17 AML 19 TRIAL 01 Y 220029174 AML19 TRIAL
220005885 220002296 0 null Curative (C) 2017-10-20 2017-11-21 AML Interim Guidelines N N 220029177 NOT MATCHED
220005886 220002296 1.66 75.7 Curative (C) null 2014-06-11 AML 19 TRIAL Y null 220029177 AML19 TRIAL
220005887 220016048 null null Curative (C) 2016-05-22 2016-05-23 Nilotinib N N 220029179 NILOTINIB
220005888 220018783 1.67 78 Curative (C) 2017-04-10 2017-04-12 AML 19 TRIAL 01 N 220029181 AML19 TRIAL
220005889 220018783 1.65 77.7 Curative (C) 2015-11-27 2015-11-27 AML 19 TRIAL 01 N 220029181 AML19 TRIAL
220005890 220018783 1.76 67 Curative (C) 2015-05-15 2015-06-04 FLAG + Idarubicin N N 220029181 FLAG + IDARUBICIN
220005891 220018783 1.6 60.6 Curative (C) 2015-03-17 2015-03-17 AML 19 TRIAL 01 N 220029181 AML19 TRIAL
220005892 220018783 1.82 75.2 Curative (C) 2015-12-23 2015-12-28 AML 19 TRIAL 01 Y 220029181 AML19 TRIAL
220005893 220018783 1.85 72.5 Disease modification (D) 2014-08-02 2014-08-02 Nilotinib N N 220029181 NILOTINIB
220005894 220018783 1.85 0 Disease modification (D) 2014-08-07 2014-08-07 Nilotinib 2 N 220029181 NILOTINIB
220005895 220018783 1.78 15.8 Curative (C) 2014-06-08 2017-05-10 BMT Fludarabine/Thiotepa/Treosulfan + ATG null N 220029181 NOT MATCHED
220005896 220018783 1.78 82.75 Curative (C) 2013-12-25 2013-12-26 AML 19 TRIAL null N 220029181 AML19 TRIAL
220005897 220018783 null 75.9 Palliative (P) 2013-08-24 2013-08-24 FLAG + Idarubicin 2 N 220029181 FLAG + IDARUBICIN
220005898 220018783 1.69 71 Curative (C) 2013-05-24 2013-05-28 AML 19 TRIAL 1 N 220029181 AML19 TRIAL
220005899 220002297 1.82 63.5 Curative (C) 2017-02-21 2017-02-21 AML 19 TRIAL 1 null 220029205 AML19 TRIAL
220005900 220002297 1.6 85.2 Curative (C) 2016-08-30 2016-08-31 AML 19 TRIAL Y N 220029205 AML19 TRIAL
220005901 220002297 1.79 null Curative (C) 2015-09-13 2015-09-14 AML Interim Guidelines FLAG-Ida null null 220029205 FLAG + IDARUBICIN
220005902 220002298 null 67.56 Curative (C) 2015-07-10 2015-07-14 AML 19 TRIAL 01 N 220029214 AML19 TRIAL
220005903 220002299 1.67 null Disease modification (D) 2017-05-04 2017-05-09 Nilotinib N N 220029219 NILOTINIB
220005904 220002299 1.91 72 Curative (C) null 2015-09-28 AML 19 TRIAL Y null 220029219 AML19 TRIAL
220005905 220002300 1.78 0 null 2013-05-22 2013-05-22 Nilotinib N N 220029222 NILOTINIB
220005906 220002301 1.74 63.1 Curative (C) 2014-04-08 2014-04-08 AML 19 TRIAL Y N 220029224 AML19 TRIAL
220005907 220002302 0 null Not known (9) 2014-09-13 2014-09-14 Nilotinib N N 220029227 NILOTINIB
220005908 220002302 1.68 6 Curative (C) 2016-06-02 2016-06-03 FLAG + Idarubicin 2 N 220029227 FLAG + IDARUBICIN